Chang Gon Kim

903 total citations
43 papers, 481 citations indexed

About

Chang Gon Kim is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Chang Gon Kim has authored 43 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Chang Gon Kim's work include Cancer Immunotherapy and Biomarkers (16 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Chang Gon Kim is often cited by papers focused on Cancer Immunotherapy and Biomarkers (16 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Chang Gon Kim collaborates with scholars based in South Korea, United States and Switzerland. Chang Gon Kim's co-authors include Byoung Chul Cho, Kyung Hwan Kim, Kyoung Kwan Ahn, Min Hee Hong, Hye Ryun Kim, Eui‐Cheol Shin, Sun Min Lim, Hyunki Kim, Mi Ran Yun and Hyo Sup Shim and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Chang Gon Kim

40 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chang Gon Kim South Korea 12 285 145 80 77 75 43 481
Yusuke Ohara Japan 11 198 0.7× 68 0.5× 80 1.0× 152 2.0× 53 0.7× 53 465
Mi Jang South Korea 16 243 0.9× 107 0.7× 28 0.3× 165 2.1× 110 1.5× 32 659
Jonathan G. Sham United States 15 339 1.2× 93 0.6× 231 2.9× 193 2.5× 76 1.0× 31 865
Ji Hyun Kwon South Korea 13 246 0.9× 91 0.6× 20 0.3× 77 1.0× 111 1.5× 32 485
Yingjie Wang China 12 117 0.4× 388 2.7× 62 0.8× 124 1.6× 94 1.3× 60 727
Michal Mauda‐Havakuk United States 9 106 0.4× 59 0.4× 108 1.4× 53 0.7× 35 0.5× 27 424
Dinesh Doval India 10 200 0.7× 179 1.2× 87 1.1× 218 2.8× 115 1.5× 32 514
Chenchen Wang China 16 238 0.8× 179 1.2× 67 0.8× 275 3.6× 185 2.5× 68 821
Xingyuan Wang China 11 428 1.5× 242 1.7× 29 0.4× 119 1.5× 69 0.9× 37 677
Shengping Li China 13 278 1.0× 126 0.9× 17 0.2× 122 1.6× 105 1.4× 28 565

Countries citing papers authored by Chang Gon Kim

Since Specialization
Citations

This map shows the geographic impact of Chang Gon Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang Gon Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang Gon Kim more than expected).

Fields of papers citing papers by Chang Gon Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang Gon Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang Gon Kim. The network helps show where Chang Gon Kim may publish in the future.

Co-authorship network of co-authors of Chang Gon Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Chang Gon Kim. A scholar is included among the top collaborators of Chang Gon Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang Gon Kim. Chang Gon Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Gamin, Jeong‐Ah Kim, Minchan Gil, et al.. (2025). Preclinical investigation of anti-tumor efficacy of allogeneic natural killer cells combined with cetuximab for head and neck squamous cell carcinoma. Cancer Immunology Immunotherapy. 74(4). 144–144. 1 indexed citations
2.
Kim, Chang Gon, Harim Koo, Woo Sun Kwon, et al.. (2025). Use of integrated multi-omics profiling in renal cell carcinoma to identify molecular subtypes and associated clinical outcomes and therapeutic vulnerabilities.. Journal of Clinical Oncology. 43(5_suppl). 588–588. 1 indexed citations
3.
Sim, Nam Suk, Gamin Kim, Dahee Kim, et al.. (2025). 4-1BB+ Tregs and inhibitory progenitor exhausted T cells confer resistance to anti-PD-L1 and anti-CTLA-4 combination therapy. Cell Reports Medicine. 6(10). 102408–102408.
4.
Heist, Rebecca S., Elaine Shum, Esther García Pagès, et al.. (2025). MYTX-011, a cMET-targeting antibody-drug conjugate (ADC), in patients with previously treated, advanced NSCLC: Updated dose escalation results in the phase 1 KisMET-01 study.. Journal of Clinical Oncology. 43(16_suppl). 8613–8613. 1 indexed citations
5.
Park, Areum, Chang Gon Kim, Jaesung Kwak, et al.. (2024). Inhibition of IRP2-dependent reprogramming of iron metabolism suppresses tumor growth in colorectal cancer. Cell Communication and Signaling. 22(1). 412–412. 7 indexed citations
6.
Kim, Chang Gon, Minkyu Jung, Hyo Song Kim, et al.. (2023). Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Advanced Gastric or Gastroesophageal Junction Cancer. Journal of Clinical Oncology. 41(27). 4394–4405. 27 indexed citations
7.
8.
Kim, Chang Gon, Nam Suk Sim, Jeong Eun Kim, et al.. (2022). Phase II Clinical Trial of Eribulin–Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or Leiomyosarcoma. Clinical Cancer Research. 28(15). 3225–3234. 6 indexed citations
9.
Kim, Chang Gon, Miso Kim, Seung Tae Kim, et al.. (2022). First-line pembrolizumab versus dabrafenib/trametinib treatment for BRAF V600–mutant advanced melanoma. Journal of the American Academy of Dermatology. 87(5). 989–996. 3 indexed citations
10.
Kim, Chang Gon, Moonki Hong, Hei‐Cheul Jeung, et al.. (2022). Hyperprogressive disease during PD-1 blockade in patients with advanced gastric cancer. European Journal of Cancer. 172. 387–399. 5 indexed citations
11.
Kim, Chang Gon, Gamin Kim, Kyung Hwan Kim, et al.. (2021). Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer. Journal for ImmunoTherapy of Cancer. 9(12). e002780–e002780. 29 indexed citations
12.
Kim, Seok‐Young, Sang-Min Kim, Su-Min Lim, et al.. (2021). Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma. Clinical Cancer Research. 27(15). 4397–4409. 88 indexed citations
13.
Kim, Jae Hwan, Young Seob Kim, Mi Ran Yun, et al.. (2021). Primary Tumor Suppression and Systemic Immune Activation of Macrophages through the Sting Pathway in Metastatic Skin Tumor. Yonsei Medical Journal. 63(1). 42–42. 10 indexed citations
14.
Kim, Kyung Hwan, Chang Gon Kim, & Eui‐Cheol Shin. (2020). Peripheral blood immune cell-based biomarkers in anti-PD-1/PD-L1 therapy. Immune Network. 20(1). e8–e8. 20 indexed citations
15.
Kim, Chang Gon, Min Hee Hong, Kyung Hwan Kim, et al.. (2020). Dynamic changes in circulating PD-1+CD8+ T lymphocytes for predicting treatment response to PD-1 blockade in patients with non-small-cell lung cancer. European Journal of Cancer. 143. 113–126. 35 indexed citations
16.
Ahn, Beung‐Chul, Kyoung‐Ho Pyo, Dongmin Jung, et al.. (2019). A machine learning based prediction model of anti-PD-1 therapy response using noninvasive clinical information and blood markers of lung cancer patients.. Journal of Clinical Oncology. 37(15_suppl). e14138–e14138. 1 indexed citations
17.
Kim, Chang Gon, Hyun Woong Lee, Hye Jin Choi, et al.. (2019). Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation. Cancer Medicine. 8(11). 5023–5032. 17 indexed citations
18.
19.
Kim, Chang Gon, et al.. (2015). The Effect of Stress Management Program for Maladjusted Soldiers. 8(1). 69–103. 2 indexed citations
20.
Lee, Jae Kyu, et al.. (1997). Case and constraint-based apartment construction project planning system: FASTrak-APT. National Conference on Artificial Intelligence. 861–866. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yusuke Ohara Breakdown of academic impact, for papers by Mi Jang Breakdown of academic impact, for papers by Jonathan G. Sham Breakdown of academic impact, for papers by Ji Hyun Kwon Breakdown of academic impact, for papers by Yingjie Wang Breakdown of academic impact, for papers by Michal Mauda‐Havakuk Breakdown of academic impact, for papers by Dinesh Doval Breakdown of academic impact, for papers by Chenchen Wang Breakdown of academic impact, for papers by Xingyuan Wang Breakdown of academic impact, for papers by Shengping Li
Rankless by CCL
2026